tumor cell secretion tissue polypeptide specificantigen (TPS) Tumor Maker Assay for Clinical In Vitro Diagnostic
CLIA Reagents of Tumor Maker(TPS)
Test Item | TPS |
Luminescent Principle | Enzymatic chemiluminescence |
Luminescent Markers | AP(alkaline phosphatase) |
Specification | 100 Test/Kit for CIA series |
Principle | Sandwich method |
Component | Magnetic Beads |
Calibrator Low | |
Calibrator High | |
Anti-A/Anti-B | |
Control 1 | |
Control 2 | |
Accessories Required But Not Provided | Substrate |
Washing solution | |
Sample material | Serum/Plasma/Whole Blood |
Storage | 2-8℃ |
Tissue polypeptide-specific antigen is a tumor marker commonly used in clinic. Tissue polypeptide-specific antigen is helpful for auxiliary diagnosis of advanced metastatic breast cancer in clinic. Tissue polypeptide-specific antigen is used in the diagnosis of advanced metastatic breast cancer. The sensitivity is higher than that of carbohydrate antigen 15-3, so the combined detection of tissue polypeptide-specific antigen and carbohydrate antigen 15-3 can further improve the sensitivity and specificity of breast cancer patients.
TPS for short, is one of the tumor markers. If the serum value is abnormally increased, it can be seen in malignant tumors such as lung cancer, breast cancer, prostate cancer, bladder cancer, and ovarian cancer.
If the tissue polypeptide-specific antigen TPS is increased, there are also some non-tumor diseases, such as acute hepatitis, pancreatitis, pneumonia and other non-tumor diseases. If there are some other diseases related to tissue polypeptide antigens such as the respiratory tract and biliary tract, there will also be some elevations.
Reference range
<55mU/ml
clinical significance
1. The serum level of TPS is generally elevated in patients with ovarian cancer, and other patients such as lung cancer and breast cancer may also have elevated serum levels;
2. TPS, together with other markers, can be used as an auxiliary index for diagnosing and tracking tumor and disease changes.